FDA approves Ofev for the treatment of scleroderma
By NewsDesk @infectiousdiseasenews On Friday, the U.S. Food and Drug Administration approved Ofev (nintedanib) capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease More...
Type 2 diabetes drug, Jardiance, receives FDA approval
The U.S. Food and Drug Administration today approved Jardiance (empagliflozin) tablets as an addition to diet and exercise to improve glycemic control in adults with type 2 diabetes. Diabetes symptomsPublic domain More...
COPD drug, Striverdi Respimat, receives FDA approval
Today, the U.S. Food and Drug Administration approved Striverdi Respimat (olodaterol) inhalation spray to treat patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema More...